Arysta LifeScience Sells for $2.2b to Europe's Biggest Buyout Firm

Arysta LifeScience, a Tokyo-based manufacturer of insecticides and other crop protection products with North American headquarters in Cary, has been purchased by Europe's largest private equity firm for $2.2 billion.

Arysta said the buyout firm, Permira Advisers, purchased the stake held in the company by another private equity group, Olympus Capital Holdings Asia.

Linda Frerichs, a local Arysta spokeswoman, said the buyout, subject to reviews and regulatory approvals, is not expected to affect the status of the 40 employees at the Cary facility.

Read the full news release